Concepedia

Author

Hanne Lind

University of Colorado Anschutz Medical CampusORCID

Also Known As

H Lind, H.T. Lind, HE Lind, Hanne Lind, Hanne T. Lind

23

Publications

627

Citations

7

H-Index

18

Concepts

All Affiliations

University of Colorado Anschutz Medical Campus
HL

About

Hanne Lind is an author at University of Colorado Anschutz Medical Campus specializing in cancer biology, tumor biology, and medicine.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

262

2

Cell Biology

2

2

262

3

Cancer Cell Biology

2

2

262

4

Pharmacology

1

1

211

5

Cancer Therapeutics

1

1

211

Hanne Lind

×

4

Publications

373

Citations

4

H-Index

YearCitations

Multiple Molecular Subtypes of Triple-Negative Breast Cancer Critically Rely on Androgen Receptor and Respond to Enzalutamide <i>In Vivo</i>

Valerie N. Barton, Nicholas C. D’Amato, Melita A. Gordon,

Molecular Cancer Therapeutics

2015

211

Simultaneous inhibition of CXCR1/2, TGF-β, and PD-L1 remodels the tumor and its microenvironment to drive antitumor immunity

Lucas A. Horn, Jeffrey Riskin, Heidi Hempel,

Journal for ImmunoTherapy of Cancer

2020

94

Inhibition of CDK-mediated Smad3 phosphorylation reduces the Pin1-Smad3 interaction and aggressiveness of triple negative breast cancer cells

Alexandra Thomas, Hanne Lind, Angela Hong,

Cell Cycle

2017

51

NPC1 Confers Metabolic Flexibility in Triple Negative Breast Cancer

Kathleen O’Neill, Li‐Wei Kuo, Michelle M. Williams,

Cancers

2022

17

Page 1